BOT 0.00% 37.5¢ botanix pharmaceuticals ltd

Ann: FDA Approves Sofdra, page-236

  1. 470 Posts.
    lightbulb Created with Sketch. 95
    Totally agree. Risk free shares for their mates while us normal holders have been subject to the risk of FDA rejection. stinks.

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.